In addition, the presence of somatostatin receptors (mainly SSTR5) and epidermal growth factor receptors (EGFR) have been linked to tumor aggressiveness and resistance to dopamine agonists (DA) (57, 63, 64, 72). This evidence concerns the gene SSTR5 and neoplasm.